在胰腺癌中功能性瘤反应性CD8+T细胞
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。这项研究引入了一种新的深度学习方法,用于在没有新抗原查的情况下识别胰腺癌中的瘤反应性CD8+T细胞. 这些已识别的细胞表现出增强的瘤杀伤能力,与免疫治疗反应和存活率的改善相关.
科学领域
- 免疫学
- 癌症学
- 计算生物学
背景情况
- 在胰腺癌中传统的瘤反应性 (TR) CD8+瘤透性淋巴细胞 (TIL) 检测依赖于新抗原表位,限制范围和复杂性.
- 现有的方法导致TR CD8+ TIL生物特征的不完全理解,因为表位范围狭窄,识别过程漫长.
研究的目的
- 开发一种新的,有效的方法来识别胰腺癌中的瘤反应性CD8+T细胞.
- 描述TR CD8+TIL的生物特征和功能能力.
- 研究TR CD8+ TIL在胰腺癌患者中的临床相关性.
主要方法
- 单细胞测序与深度学习 (DL) 的整合,用于新抗原独立识别TR CD8+ T细胞.
- 使用T细胞受体工程T (TCR-T) 细胞瘤器官杀死模型验证DL识别的TR CD8+T细胞功能.
- 采用空间转录组学来确认受体-连接体相互作用,并进行T细胞受体 (TCR) 谱分析.
主要成果
- DL 发现的 TR CD8+ TIL 显示出由 FOS 调节的线粒体呼吸链通路受损.
- 在胰腺癌微环境中,TIGIT-NECTIN2轴被确定为一个关键的免疫检查点.
- 具有多个TCRβ组合的TR CD8+TIL显示出较高的瘤杀伤能力;较高的比例与更好的免疫治疗反应和存活率相关.
结论
- 这项研究有助于进一步了解胰腺癌中的TR TIL生物学.
- 已经建立了一个快速而准确的方法来识别TR CD8 TIL.
- 这些发现为免疫检查点向和TCR-T细胞治疗策略提供了洞察力.
相关概念视频
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...